• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Ecancermedicalscience

    Ecancermedicalscience

    JournalISSN 1754-6605eISSN 1754-6605中科院 医学 4区

    年发文量

    研究主题

    论文(2380)

    排序
    1‘This Integration Should Have Started Yesterday’: Acceptability of Integrated Cervical Screening in HIV Care among Health Workers in Kampala, Uganda
    Noleb Mugume Mugisha,Warren Phipps,Jackson Orem,Ruanne Barnabas,Dan Kabonge Kaye,Lynn Atuyambe
    2026
    引用
    AI阅读
    加入学术空间
    2Intended and Completed Treatment Pathways in Non-Metastatic Oesophageal Cancer Treated with Chemoradiotherapy: Real-World Survival and Swallowing Outcomes
    Nikhil Bathija,Rohit Mahajan, Anil Kumar Goel, Siva Ranjani, Mounika Sirimalla,Gourav Kaushal,Sapna Marcus, Shilpa Jain, Mahur Verma, Deep Shikha, Korukonda Vinod Kumar, Jyoti Sharma
    2026
    引用
    AI阅读
    加入学术空间
    3Validation of the Spanish Version of the Shame and Sigma Scale for Head and Neck Cancer Survivors
    Loreto Fernández-González, R. Lagos, Piero Bettoli, Loreto Moreira, Jaime Sapag, D. Kissane

    Head and neck cancer (HNC) and its treatments can pose significant psychosocial challenges for survivors, including feelings of shame and stigma, which can worsen quality of life and survivorship. We aimed to test the psychometric properties of the Chilean Spanish version of the shame and stigma scale on a sample of head and neck cancer survivors. Methods: The SSS is a 20-item self-administered questionnaire that assesses shame and stigma associated with HNC. A cross-sectional, descriptive, psychometric validation study was conducted in a private non-profit cancer centre in Santiago de Chile. Participants were over 18 years of age who finished active treatment for HNC at any stage, were fluent in Spanish and were cognitively able to participate. Reliability was analysed using Cronbach’s alpha, and confirmatory factor analysis (CFA) was performed following the model of the original scale. Results: A total of 120 HNC survivors participated in the study (39% women). The median age was 63 years. The reliability analysis yielded a value of alpha = 0.92 (IC = 0.89–0.94), leading to the removal of one item to optimise internal consistency. Confirmatory factor analysis using the robust weighted least squares estimator with a one-factor structure yielded a Comparative Fit Index (CFI) of 0.984, a Root Mean Square Error of Approximation (RMSEA) of 0.098, a Standardised Root Mean Square Residual (SRMR) of 0.112 and a Tucker-Lewis Index (TLI) of 0.982. The four-factor model showed improved fit indices, with CFI = 0.997, RMSEA = 0.044, SRMR = 0.089 and TLI = 0.996, suggesting that the four-factor structure provides a better representation of the data under estimation. Conclusion: SSS-Sp is psychometrically

    2026
    引用
    AI阅读
    加入学术空间
    4The Evidence Base of Clinical Practice Guidelines for Cancer in China, the Hong Kong SAR and Taiwan
    Wei-Ting Wei, G. Lewison,Richard Sullivan

    We investigated the evidence base of Clinical Practice Guidelines (CPGs) on 10 major cancers from mainland China, the Hong Kong Special Administrative Region and Taiwan. We sought information about the delays between publication of the CPGs and their respective references, the geographical origins of the research reported in these references and the sources of funding for this research. We identified 396 CPGs from China, 42 from Hong Kong and 54 from Taiwan for ten major cancers, and 12,556, 3,652, and 4,485 references to these CPGs in the three territories, respectively. We determined the countries of the authors (for the non-Chinese references) and the Chinese provinces or cities (for the references in Chinese) and also analysed the funding sources for the research. Some 22% of the references cited in the CPGs from China were in Chinese, and some of their references were based on Traditional Chinese Medicine (TCM), particularly in mainland China and for gastrointestinal cancers. The references in the Chinese CPGs tended to cite Chinese research less than expected, but Japanese research rather more – as did the references in the Hong Kong and Taiwanese CPGs, which over-cited research from their own territories. The sources of financial support for the international references were mainly public grant-giving bodies and pharmaceutical companies from the USA, Japan and Europe, rather than the main Chinese governmental funders. The rapidly increasing Chinese cancer research output will make the latter funding sources more important in future, and they may also be expected to influence the evidence base of the Hong Kong and Taiwanese CPGs. However, since Chinese cancer research is very basic (rather than clinical), its direct influence on cancer care is likely to be less than might be expected.

    2026
    引用
    AI阅读
    加入学术空间
    5High Burden of Germline Variants of Uncertain Significance in Advanced Renal Cell Carcinoma: Insights from an Indian Cohort
    Pavan Raju Kola, Amith Paruchuri, Nimisha Preman,Hemavathi Baskarane, Vishakha Hooda,Aparna Sharma,Ishaan Gupta, Saran Kumar,Shilpi Minocha,Pranay Tanwar,Mohit Kumar Divakar,Atul Batra
    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 2380 篇论文

    高被引作者

    作者引用发文
    Vikas P. Sukhatme158110
    Pan Pantziarka152018
    Gauthier Bouche142413
    Sukhatme Vidula138211
    Meheus Lydie113411
    Mieke Van Hemelrijck101914
    Beth S. Russell8994
    Charlotte Moss8993
    Gianni Ciofani7391
    Carlotta Pucci7391

    高产作者

    作者引用发文
    Richard Sullivan54838
    Kumar Prabhash20836
    Vanita Noronha20235
    Vijay M Patil20030
    Rachel Riechelmann31727
    Nandini Menon9426
    Gabriella Pravettoni47920
    Amit Joshi13519
    Bishal Gyawali28619
    Julia Downing9218

    相关期刊

    Acta oncologica
    Tumori
    Cancer control : journal of the Moffitt Cancer Center
    Current Oncology Reports
    Cancer Epidemiology
    Cancer reports
    JCO global oncology
    ESMO Open
    Cancer Treatment and Research Communications
    Asia-Pacific Journal Of Clinical Oncology